Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)-Reference-Cited by-同舟云学术

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

Published:2012-08 Issue:8 Volume:14 Page:909-915
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Preiss David¹,van Veldhuisen Dirk J.²,Sattar Naveed¹,Krum Henry³,Swedberg Karl⁴,Shi Harry⁵,Vincent John⁵,Pocock Stuart J.⁶,Pitt Bertram⁷,Zannad Faiez⁸,McMurray John J.V.¹

Affiliation:

1. British Heart Foundation Cardiovascular Research Centre; University of Glasgow; Glasgow G12 8TA UK

2. Department of Cardiology, Thorax Center; University Medical Center; Groningen The Netherlands

3. Department of Epidemiology and Preventive Medicine, Centre of Cardiovascular Research and Education in Therapeutics; Monash University; Melbourne Australia

4. Department of Emergency and Cardiovascular Medicine, Sahlgrenska Academy; University of Gothenburg; Gothenburg Sweden

5. Pfizer; New York USA

6. Department of Medical Statistics; London School of Hygiene and Tropical Medicine; London UK

7. University of Michigan School of Medicine; Ann Arbor MI USA

8. INSERM, Centre d'Investigation Clinique 9501 and Unité 961, Centre Hospitalier Universitaire, and the Department of Cardiology; Nancy University; Nancy France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfs067/fullpdf

Reference25 articles.

1. Diabetes, left ventricular systolic dysfunction, and chronic heart failure;MacDonald;Eur Heart J,2008

2. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program;Preiss;Diabetes Care,2009

3. Scherhag A; COMET investigators. Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET);Torp-Pedersen;Heart,2007

4. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis;Elliott;Lancet,2007

5. Effect of valsartan on the incidence of diabetes and cardiovascular events;McMurray;N Engl J Med,2010

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure and Diabetes;Textbook of Diabetes;2024-01-12

2. Mineralocorticoid receptor antagonists for chronic heart failure: a meta-analysis focusing on the number needed to treat;Frontiers in Cardiovascular Medicine;2023-11-06

3. Metabolic Approaches for the Treatment of Dilated Cardiomyopathy;Journal of Cardiovascular Development and Disease;2023-07-05

4. The Prognostic Efficacy of DPP-4 Inhibitors in Asian HFpEF;JACC: Asia;2023-02

5. Heart Failure and Cardiac Dysfunction in Diabetes;Diabetes and Cardiovascular Disease;2023